1. Home
  2. ELUT vs NEPH Comparison

ELUT vs NEPH Comparison

Compare ELUT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.84

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.56

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
NEPH
Founded
2015
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.5M
39.0M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
ELUT
NEPH
Price
$0.84
$3.56
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
★ 100.2K
38.4K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
146.77
★ 1000.00
EPS
N/A
★ 0.12
Revenue
$12,293,000.00
★ $18,789,000.00
Revenue This Year
N/A
$17.81
Revenue Next Year
N/A
$15.90
P/E Ratio
★ N/A
$29.75
Revenue Growth
N/A
★ 32.67
52 Week Low
$0.50
$2.66
52 Week High
$1.39
$6.42

Technical Indicators

Market Signals
Indicator
ELUT
NEPH
Relative Strength Index (RSI) 50.91 44.10
Support Level $0.74 $3.19
Resistance Level $0.87 $3.78
Average True Range (ATR) 0.06 0.28
MACD 0.01 0.03
Stochastic Oscillator 65.53 69.23

Price Performance

Historical Comparison
ELUT
NEPH

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: